📄 AETHLON MEDICAL INC

📄 AETHLON MEDICAL INC Aethlon Medical is a medical therapeutic company developing the Hemopurifier, a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The device utilizes proprietary lectin-based technology to remove harmful viruses and exosomes from biological fluids. The FDA has designated the Hemopurifier as a 'Breakthrough Device' for treating advanced cancer and life-threatening viruses not addressed with approved therapies. Key risk: The failure by management to apply the net proceeds from this offering effectively could result in financial losses that could have a material adverse effect on our business and cause the price of our common stock to decline.

Aethlon Medical is a medical therapeutic company developing the Hemopurifier, a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The device utilizes proprietary lectin-based technology to remove harmful viruses and exosomes from biological fluids. The FDA has designated the Hemopurifier as a 'Breakthrough Device' for treating advanced cancer and life-threatening viruses not addressed with approved therapies.